ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

121
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
Refresh
bullishKakaoBank
07 Aug 2021 17:53

Kakao Bank - MSCI Done, Missed FTSE by a Whisker.

Kakao Bank (KB), South Korea’s largest digital bank, raised US$2.2bn in its South Korean IPO. It ended the first day of trading up 79% from its IPO...

Logo
348 Views
Share
bullishKrafton
12 Jul 2021 08:01

A Guide to Notable Korean Sector Indices

Among the hundreds of local sector-themed indices, indices with significant AUM and passive impact are summarized in this post.

Logo
223 Views
Share
bearishKakao Games
18 Jun 2021 11:18

KRX BBIG Index Rebalance Preview: Worth a Look

There are lots of changes expected to the KRX BBIG indices at the September review. With a large amount of assets tracking the indices, some of the...

Logo
469 Views
Share
bullishKrafton
16 Jun 2021 08:43

Krafton IPO Preview

According to the bankers' valuation, the expected market cap of Krafton is expected to be from 23.7 trillion won to 28.8 trillion won.

Logo
303 Views
Share
22 May 2021 14:54

KOSPI 200 Rebalancing: Constituents with a ±5%pt Free Float Change

This post looks into KOSPI 200 constituents with a potential ±5%pt free float change in the upcoming rebalancing. It then examines the extent of...

Logo
332 Views
Share
x